Major Institutional Investors Reduce Valneva Stake After Not Participating in €84M Offering

summarizeSummary

Major institutional investors Bpifrance and Caisse des Depots updated their Schedule 13D, reporting a diluted stake after not participating in Valneva's recent €84 million offering and detailing net share sales totaling approximately $2.14 million.

check_boxKey Events · Ownership and Investor Activity · VALN

• Dilution from Reserved Offering

  The reporting persons (Bpifrance and Caisse des Depots) did not participate in Valneva's recent €84 million reserved offering, which resulted in a dilution of their ownership percentages.

• Bpifrance Participations Sells Shares

  Bpifrance Participations S.A. sold 356,003 ordinary shares for approximately €1.76 million in open market transactions during March 2026.

• CDC Croissance Net Sales

  CDC Croissance S.A. acquired 130,000 ordinary shares for approximately €0.59 million and sold 289,645 ordinary shares for approximately €0.81 million in March 2026, resulting in net sales of approximately €0.22 million.

• Updated Ownership Stake

  As of May 5, 2026, Bpifrance Participations holds 7.0% of voting rights, and Caisse des Depots et consignations holds 9.3% of voting rights, reflecting the impact of the offering and recent transactions.

auto_awesomeAnalysis · VALN · Life Sciences

This Schedule 13D/A updates the holdings of major institutional investors, Bpifrance and Caisse des Depots, following Valneva's recent €84 million reserved offering. These investors chose not to participate in the offering, resulting in a dilution of their ownership percentages. Additionally, the filing details recent open market transactions, including Bpifrance Participations selling approximately €1.76 million worth of shares and CDC Croissance making net sales of approximately €0.22 million. This indicates a reduction in their overall stake, both actively through sales and passively through non-participation in the capital raise.